Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer

Recently, the use of immune checkpoint inhibitors (ICIs) with or without chemotherapeutic agents has been increasing in the treatment for advanced cancer. Here, we report the occurrence of liver failure after the use of pembrolizumab in an 82‐year‐old woman with metastatic liver disease derived from...

Descripción completa

Detalles Bibliográficos
Autores principales: Asatani, Shinya, Kanda, Tatsuo, Honda, Masayuki, Ishii, Tomotaka, Yamana, Yoichiro, Kaneko, Tomohiro, Mizutani, Taku, Takahashi, Hiroshi, Kumagawa, Mariko, Sasaki, Reina, Masuzaki, Ryota, Kanezawa, Shini, Matsumoto, Naoki, Nirei, Kazushige, Yamagami, Hiroaki, Moriyama, Mitsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171158/
https://www.ncbi.nlm.nih.gov/pubmed/34124393
http://dx.doi.org/10.1002/jgh3.12554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171158/
https://www.ncbi.nlm.nih.gov/pubmed/34124393
http://dx.doi.org/10.1002/jgh3.12554

Ejemplares similares